GNOM Share Price

Open 3.15 Change Price %
High 3.16 1 Day -0.01 -0.32
Low 3.14 1 Week 0.00 0.00
Close 3.14 1 Month 0.00 0.00
Volume 56135 1 Year 0.00 0.00
52 Week High 13.29
52 Week Low 4.20
GNOM Important Levels
Resistance 2 3.16
Resistance 1 3.15
Pivot 3.15
Support 1 3.13
Support 2 3.12
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
ETRM 0.07 40.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
MU 20.66 1.08%
MU 20.66 1.08%
More..
NASDAQ USA Top Gainers Stocks
SSH 0.58 176.19%
SSH 0.58 176.19%
SSH 0.58 176.19%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
MBLX 0.51 64.52%
COOL 5.17 63.61%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
SHIP 1.20 -45.45%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Complete Genomics, Inc. (NASDAQ: GNOM)

GNOM Technical Analysis 4
As on 18th Mar 2013 GNOM Share Price closed @ 3.14 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.78 & Buy for SHORT-TERM with Stoploss of 3.13 we also expect STOCK to react on Following IMPORTANT LEVELS.
GNOM Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
Complete Genomics, Inc. ( NASDAQ USA Symbol : GNOM )
Sector : Health Care Biotechnology: Commercial Physical & Biological Resarch And Other Stocks in Same Sector
GNOM
3.14 -0.01 (-0.32 %)
LT : Strong Buy
ST : Buy
MAXY
2.53 -0.01 (-0.39 %)
LT : Buy
ST : Buy
NRCI
60.10 -0.65 (-1.07 %)
LT : Buy
ST : Buy
OXBT
4.04 0.02 (0.50 %)
LT : Sell
ST : Buy
GNOM Other Details
Segment EQ
Market Capital 103658792.00
Sector Health Care Biotechnology: Commercial Physical & Biological Resarch
Industry
Offical website
GNOM Address
GNOM
N/A
GNOM Latest News
Complete Genomics Laying off 186 Employees   GenomeWeb   - 02nd Dec 15
Mountain View's Complete Genomics sheds jobs, changes mission   Silicon Valley Business Journal   - 02nd Dec 15
Complete Genomics Loses Staff, Delays Revolocity as BGI Seeks Support for ...   Bio-IT World   - 24th Nov 15
BGI Halts Revolocity Launch, Cuts Complete Genomics Staff as Part of Strategic ...   GenomeWeb   - 24th Nov 15
Photo Release -- Complete Genomics Appoints Ethan Knowlden as Senior Vice ...   GlobeNewswire (press release)   - 17th Sep 13
Illumina, Complete Genomics Settle Patent Disputes   Law360 (subscription)   - 19th Jul 13
BGI-Shenzhen Acquires US-Based Complete Genomics For $117M   Asian Scientist Magazine   - 19th Mar 13
Chinese Company to Acquire DNA Sequencing Firm   New York Times   - 17th Sep 12
Complete Genomics CEO on DNA Sequencing Capacity   Washington Post   - 30th Jan 12
Complete Genomics Prices IPO Below Range   Seeking Alpha   - 12th Nov 10
Interactive Technical Analysis Chart Complete Genomics, Inc. ( GNOM NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Complete Genomics, Inc.
GNOM Business Profile
Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.